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ABSTRACT 
Among the toxic polypeptides secreted in the 
venom of sea anemones, actinoporins are pore 
forming toxins whose toxic activity relies on the 
formation of oligomeric pores within biological 
membranes. Intriguingly, actinoporins appear as 
multigene families which give rise to many protein 
isoforms in the same individual displaying high 
sequence identities but large functional 
differences. However, the evolutionary advantage 
of producing such similar isotoxins is not fully 
understood. Here, using sticholysins I and II (StnI 
and StnII) from the sea anemone Stichodactyla 
helianthus, it is shown that actinoporin isoforms 
can potentiate each other’s activity. Through 
hemolysis and calcein releasing assays, it is 
revealed that mixtures of StnI and StnII are more 
lytic than equivalent preparations of the 
corresponding isolated isoforms. It is then 
proposed that this synergy is due to the assembly 
of heteropores since (i) StnI and StnII can be 
chemically cross-linked at the membrane and (ii) 
the affinity of sticholysin mixtures for the 
membrane is increased with respect to any of them 
acting in isolation, as revealed by isothermal 
titration calorimetry experiments. These results 
help to understand the multigene nature of 
actinoporins and may be extended to other families 
of toxins that require oligomerization to exert 
toxicity. 
 
Actinoporins constitute a family of toxic proteins 
produced by different sea anemone species as 
single polypeptide chains of around 175 amino 
acids. They show basic isoelectric point values and 
are usually cysteineless (1-4). Actinoporins belong 
to a much larger group of widely distributed 
proteins, known as pore forming toxins (PFT), 
whose toxic activity relies on the formation of 
pores within biological membranes (5-9). All PFTs 
show a very similar dual behavior by which they 
remain mostly monomeric and stably folded in 
aqueous solution but become oligomeric integral 
proteins when encountering membranes (2-4,10-
23). 
The incorporation of actinoporins into the 
membrane largely depends on lipid bilayer 
composition and membrane physicochemical state 
(18,24-29). Both factors influence the 
conformational changes occurring during the 
transition from the water media to the inserted 
states of the protein (30,31). Thus, high affinity 
recognition of sphingomyelin (SM) is crucial for 
specific attachment to a membrane but the 
subsequent effects observed also depend on the 
physical properties derived from its particular 
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composition and not only from its SM content 
(23,32). In fact, although still controversial, the 
presence of cholesterol and coexistence of 
different phases in the membrane seem to be 
important factors, if not for binding, at least for the 
final formation of the pore (23,28,29,32-36). 
Actinoporins have been isolated from 
more than 20 different sea anemone species 
(1,3,37-41) in agreement with their rather 
ubiquitous distribution within the Actinaria order 
(1). They display high sequence identities 
(between 60% and 80%) and appear as multigene 
families, giving rise to many protein isoforms 
within the same individual (42-46). Despite the 
small number of amino acid changes between 
them, actinoporin isoforms usually result in 
substantial functional differences in terms of 
solubility and lytic activity (38,45,47-51), as 
exemplified by StnI and StnII, produced by 
Stichodactyla helianthus, and also two of the best 
characterized actinoporins (3,4,20,22,24,47-
50,52). 
The reason why a single anemone 
produces several isoforms of actinoporins in its 
venom is still not fully understood. One possible 
explanation would be to expand the range of prey 
susceptible of being attacked (53). Such a strategy 
would extend and modulate the range of sea 
anemones action. It has even been proposed an 
analogy with immunoglobulins which suggests 
that sea anemone tentacles would produce many 
actinoporins isoforms because they would 
represent the embryo of a rudimentary defense 
system (45). However, so far the possibility that 
these different isoforms show synergistic activity 
has not been explored. This possibility is 
interesting since it would lead to more efficient 
venoms. The results presented here not only prove 
that StnI and StnII potentiate their lytic activity 
when they act together, but also indicate that they 
can establish functional heteropores, suggesting 
that actinoporins have a more deeply regulated 
physiological mode of action than previously 
believed. 
EXPERIMENTAL PROCEDURES 
Materials - 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), cholesterol (Chol), and 
porcine brain sphingomyelin (SM) were obtained 
from Avanti Polar Lipids. Disuccinimidyl suberate 
(DSS) was purchased from Pierce (Thermo 
Scientific). The preparation of the cDNA coding 
for StnI, StnII and the six His tagged version of 
StnII (6HStnII), as well as the production and 
purification of the three different proteins, has 
been described before (30,50,54). Homogeneity of 
all protein samples used was analyzed by 0.1% 
(w/v) SDS/12-15% (w/v) PAGE performed in 
standard conditions (55) and amino acid analysis 
after acid hydrolysis of the proteins (5.7 M HCl, 
24 h, 110°C). These amino acid analyses were 
performed on a Biochrom 20 automatic analyzer 
(Pharmacia). All protein batches used were also 
previously characterized in terms of recording 
their far-UV circular dichroism (CD) spectra on a 
Jasco 715 spectropolarimeter, also as described 
(20,21,56,57). 
Hemolysis - Hemolysis assays were 
performed in 96-multiwell plates as previously 
described (30,50). Briefly, erythrocytes from 
heparinized sheep blood were washed in 10 mM 
Tris buffer, pH 7.4, containing 145 mM NaCl, to a 
final OD655 of 0.5 when mixing equal volumes of 
the cell suspension and buffer. The hemolysis was 
followed as a decrease in OD655 after addition of 
the erythrocyte suspension to different final 
concentrations of protein. An Expert 96 microplate 
reader (Asys Hitech, GmbH, Eugendorf, Austria) 
was employed to measure OD655. The value 
obtained with 0.1% (w/v) Na2CO3 was considered 
as 100% hemolysis. 
Lipid vesicle preparation - 
DOPC:SM:Chol (1:1:1) phospholipid vesicles 
were prepared as previously described (20,23,58). 
A phospholipid (0.1–1.0 mg) solution in 2:1 (v/v) 
chloroform/methanol was dried under a flow of 
nitrogen, and the dry film obtained was used to 
prepare a lipid dispersion by adding 0.5-2.0 mL of 
Tris/NaCl (10 mM Tris–HCl, pH 7.4, 140 mM 
NaCl), briefly vortex-mixing, and incubating for 1 
h at 37 ºC. This suspension of multilamellar 
vesicles was further subjected to five cycles of 
extrusion at 37 ºC through polycarbonate filters 
(100-nm pore size) to obtain a homogeneous 
population of unilamellar vesicles. 
Calcein leakage assays - Calcein-
entrapped DOPC:SM:Chol (1:1:1) large 
unilamellar vesicles (LUVs) were prepared as 
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described (23) by extrusion through 100 nm filters 
(Nucleopore, Whatman) at 37 °C. Briefly, the 
desired lipids were mixed and dried under a stream 
of nitrogen. The lipids were re-dissolved in 
chloroform and dried again before removal of any 
traces of remaining solvent in vacuum for 60 min. 
Prior to extrusion, the dry lipid films were 
hydrated for one hour at 37 °C in Tris buffer (10 
mM Tris, 140 mM NaCl, 0.5 mM EDTA pH 7.4), 
containing 100 mM calcein. The total lipid 
concentration was 1.25 mM. LUVs were separated 
from non-entrapped calcein by gel filtration on 
Sephacryl S200HR. These LUVs were used for 
permeabilization studies within 24 h. Phospholipid 
concentration was determined from phosphorous 
measurement (59) after elution of vesicles during 
isolation. The concentration of LUV phospholipids 
and protein during calcein leakage experiments 
were about 7.5 μM and 1-80 nM, respectively. 
Emission at 550 nm was followed at 23 °C as a 
function of time (excitation at 480 nm). 
Fluorescence emission was measured with an SLM 
Aminco 8000 spectrofluorimeter. To ensure that 
no major spontaneous leakage occurred, the 
emission was measured for each sample during 5 
min before addition of toxin. A steady signal level, 
indicating intact vesicles, was observed for all 
samples. Maximum calcein release was 
determined upon LUV disintegration induced by 
10% Triton X-100. 
Cross-linking experiments - Cross-linking 
was performed essentially as described before 
(60). DSS was used as the cross-linking reagent in 
a reaction which was performed by adding a small 
aliquot of a concentrated freshly prepared cross-
linker solution to the protein sample, at the 
required concentrations. Protein (wild-type StnI 
and a 6 x His tagged version of StnII [6HStnII]) 
(50) and vesicle mixtures were prepared in 15 mM 
MOPS, pH 7.4, containing 50 mM NaCl, at the 
following final molar concentrations: 2.0 µM StnI, 
0.5 µM 6HStnII, 0.1 µM (lipid concentration) 
DOPC:SM:Chol (1:1:1) phospholipid vesicles, and 
0.04 µM DSS. The final concentration of each 
protein employed was in this case independent of 
the presence or not of the other actinoporin. A 
second set of cross-linking experiments were made 
with mixtures containing a constant concentration 
of 6HStnII and increasing amounts of StnI up to a 
StnI:6HStnII molar ratio of 95:5. The cross-linker 
was dissolved in dimethyl sulfoxide (DMSO). The 
protein-lipid reaction mixtures were incubated at 
37 ºC for 1 hour, then the cross-linker was added 
and kept for 30 minutes at room temperature, and 
finally the mixtures were quenched for 15 min by 
adding an aliquot of the same buffer but containing 
50 mM Lys. After addition of the corresponding 
electrophoresis loading buffer to each aliquot, they 
were boiled for 20 min in the presence of 0.5% 
(v/v) β-mercaptoethanol and the cross-linked 
products were analyzed by SDS-PAGE following 
standard procedures (55). Western immunoblotting 
was used to detect 6HStnII using a mouse 
monoclonal anti-poly-Histidine-peroxidase 
antibody from Sigma-Aldrich. 
Protein binding to lipid vesicles - Binding 
was measured using isothermal titration 
calorimetry (ITC) as described before (21,30,61), 
using a VP-ITC calorimeter (MicroCal). Briefly, 
protein solutions at 1.5-10.0 μM concentration 
were titrated by injection of 10 or 20 μL aliquots 
of lipid suspensions (phospholipid concentration: 
0.85-5.00 mM). Binding isotherms were adjusted 
to a model were the protein binds to the membrane 
involving “n” lipid molecules (30). 
RESULTS 
StnI and StnII show synergistic hemolytic 
activity - A hemolysis experiment was designed to 
study the potential formation of StnI/StnII 
heteropores and its functional consequences. 
Within this idea, sheep erythrocyte hemolysis was 
assayed in the presence of isolated StnI or StnII at 
different concentrations or for a mixture of 
StnI:StnII at 80:20 constant molar ratio (Fig. 1). 
This experiment was so designed given the lower 
hemolytic activity of StnI. Inspection of results 
shown in Fig. 1 reveal how the mixture produced 
higher hemolysis rates than that one resulting from 
the arithmetical combination of the corresponding 
values obtained with the individual proteins. 
In order to evaluate the specificity of this 
observation two different StnII mutants were 
employed as controls. First, the same experiment 
as that described in Fig. 1 was made using StnII 
A10PS28P instead of the wild-type protein. This 
mutant has been previously described as retaining 
its full membrane binding activity but showing a 
highly diminished pore forming ability due to its 
3 
 
Functionally active actinoporin heteropores 
inability to extend the needed α helical stretch 
(30). As shown in Fig. 2A, even though the mutant 
was completely unable to lyse the erythrocytes 
within the full concentration range assayed, the 
mixture still produced higher hemolysis rates than 
those ones resulting from the arithmetical 
combination of the corresponding values obtained 
with the individual proteins (wild-type StnI and 
A10PS28P StnII at a 80:20 ratio). 
In the second control experiment 
performed, the StnII mutant used was Y111N. In 
this StnII variant a key residue of the so called 
phosphocholine (POC)-binding site has been 
replaced rendering a protein which cannot bind to 
the membrane and, therefore, shows a dramatically 
reduced hemolytic activity (30,54). It can be seen 
how in this case (Fig. 2B) the synergic effect of 
StnII is not observed. 
Overall, the three sets of experiments 
suggest not only the existence of synergistic action 
between both actinoporin isoforms, StnI and StnII, 
but also that this synergy seems to occur at the 
membrane binding step of the pore formation 
mechanism 
StnI and StnII show synergistic lytic 
activity towards lipid model vesicles – 
Erythrocytes are a rather complex model system to 
study protein-lipid interactions and assembly of 
pores at the membrane. Therefore, an experiment 
was designed to study leakage of calcein-
containing DOPC:SM:Chol (1:1:1) phospholipid 
vesicles upon addition of different actinoporin 
concentrations. This type of vesicles represents 
one of the standard models most widely used to 
characterize StnI and StnII pore formation 
behavior (18,20,23,28,30,54,62). As it can be 
observed in Fig. 3, the results obtained were 
similar to those ones corresponding to the 
hemolysis assays. The mixture of StnI and StnII 
produced higher calcein release rates than that one 
resulting from the arithmetical combination of the 
corresponding values obtained with the individual 
proteins. 
StnI and StnII can be cross-linked in the 
presence of lipid membranes - The results obtained 
from both sets of activity experiments, hemolysis 
and calcein release assays, show that StnI and 
StnII display synergistic activity. One explanation 
for this synergy would be the formation of active 
StnI/StnII heteropores. If this was the case, 
molecules of both different proteins studied should 
be in enough proximity as to be cross-linked using 
a short bifunctional reagent such as DSS (spacer 
arm: 1.1 nm), which reacts against exposed 
primary amines. Consequently, mixtures of StnI 
and StnII were incubated in the presence or 
absence of DOPC:SM:Chol (1:1:1) phospholipid 
vesicles and then DSS was added, following a 
standard protocol (63). The resulting mixture of 
proteins was analyzed by means of SDS-PAGE 
followed by Western blotting and 
immunodetection. For this purpose, instead of the 
wild type protein, a 6xHis tagged version of StnII 
(6HStnII) was employed. This protein has been 
described to retain the general features and 
molecular mechanism of wild-type StnII (50,64). 
This 6HStnII variant shows two advantages for 
cross-linking experiments. First, the presence of 
the N-terminus polyHis tag shifts its 
electrophoretic mobility to the point that it can be 
unequivocally distinguished from wild-type StnI 
(50). Second, it can be identified by an anti-poly-
His antibody without cross-reactivity from StnI 
(18). Therefore, the results presented in blots of 
Figs. 4 and 5 reveal only the presence of 6HStnII, 
independently of the amount of StnI present. 
In the absence of vesicles, only 6HStnII is 
detected in lanes 1 and 2 of Fig. 4 in spite of the 
presence of a four-fold higher concentration of 
StnI or the previous addition, or not, of the cross-
linking agent. Lanes 3 and 4 show the same set of 
results, cross-linked or not, but this time after 
incubation of both proteins with DOPC:SM:Chol 
(1:1:1) vesicles. Thus, again, in the absence of 
DSS, no other band but that one corresponding to 
monomeric 6HStnII was observed (lane 3). 
However, when the cross-linker was present new 
bands of different electrophoretic mobility were 
evident (Fig.4, lane 4). At least two of these bands 
were not observed if 6HStnII (lane 5) or StnI (lane 
6) were the only proteins present. Therefore, they 
can only correspond to hetero-oligomers made of 
6HStnII and wild-type StnI, the only situation that 
would explain their immunodetection by the anti-
poly-His antibody altogether with their singular 
electrophoretic mobility. It has been well 
determined that the presence of the six His tag at 
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the N-terminal end of sticholysins has a deep 
impact on their electrophoretic mobility (50) 
In order to show further evidence of the 
assembly of StnI and 6HStnII into cross-linkable 
heteropores, the titration experiment shown in Fig. 
5 was performed. Again, in these conditions, in the 
absence of vesicles, only 6HStnII was detected in 
lane 1. However, when crosslinker and vesicles 
were present, 6HStnII cross-linked oligomers 
could be detected (lane 2). In fact, the observed 
distribution pattern is very similar to that one 
reported before for EqtII under almost identical 
conditions (25,65). As shown in lanes 2 to 5, upon 
increasing the StnI:6HStnII ratio the appearance of 
the bands corresponding to cross-linked proteins is 
increasingly evident altogether with a decrease of 
the monomeric 6HStnII species. This second set of 
results does not only confirm the presence of 
cross-linkable heteropores on the bilayer but also 
its marked protein concentration and StnI/6HStnII 
ratio dependence. The presence of other hetero-
oligomers of lower electrophoretic mobility is also 
detected but, given the inherent influence of the 
DSS reaction on band electrophoretic mobility and 
sharpness (60), it is not possible to assign specific 
stoichiometries. We also used Coomassie staining 
to analyze the results of crosslinking. Comparing 
with the western blot results, we found that the 
lower mobility heteroligomer bands at around 
40KDa that become apparent at higher 
StnI:6HStnII ratios have a lower reactivity against 
the anti-His antibody, in agreement with the lower 
content of His-tags in the heteroligomers. 
In summary, this set of experiments 
allowed to conclude that, in the presence of 
membranes, actinoporins StnI and StnII are closely 
enough as to be cross-linked by a short 
crosslinking agent, suggesting that heteropores of 
StnI and StnII are formed. 
Mixtures of StnI and StnII show increased 
membrane affinity – The actinoporins pore-
formation mechanism has been thoroughly studied 
although some of its details are still subject of 
dispute (17,32,66-70). In a simplified version of 
this mechanism, two different steps can be 
distinguished: First, the protein binds to the 
membrane and, second, assembles into a 
functional oligomeric pore (18,30). Within the 
context of this simplified picture, it can be 
assumed that binding assays by isothermal titration 
calorimetry (ITC) measure the affinity of the 
proteins to the membrane (30). As it can be 
observed in Fig. 6, the affinity of StnI for 
DOPC:SM:Chol (1:1:1) phospholipid vesicles is 
lower than that one corresponding to StnII (Table 
1). In terms or relative membrane binding affinity 
(RMB), StnII binding to the vesicles is four fold-
higher, a result that is good enough by itself to 
explain the long-known differences in terms of 
hemolytic and calcein-leakage activities between 
StnI and StnII (26,71). 
In order to explore whether improved 
binding could contribute to the synergistic lytic 
activity shown by sticholysins, we performed ITC 
binding experiments in which a total actinoporin 
concentration was fixed but different StnI/StnII 
molar ratios were assayed (Fig. 7). Quite 
surprisingly, the binding affinity of mixtures of 
StnI and StnII was always higher than for any of 
the two actinoporins acting in isolation. This effect 
was already detected in the presence of trace 
amounts (1.0%) of StnII and correlated with 
increased RMB (Fig. 7 and Table 1). It is difficult 
to conceive how the binding affinity could 
increase without direct interaction between StnI 
and StnII. Hence, the ITC experiments lend 
additional support to the hypothesis that StnI and 
StnII can assemble into functional heteropores, 
leading to synergistic lytic activity. 
Finally, given the large effect on affinity 
of only traces of StnII in the mixtures, it was 
studied if this increase in binding affinity was 
directly correlated with an enhancement of 
function. As can be seen in Fig. 8, just 1.0% of 
StnII in the mixtures was enough to dramatically 
improve their hemolytic activity, as revealed by 
the hemolysis assays performed with different 
StnI:StnII (99:1) mixtures over a 1-10 nM 
concentration range (Fig. 8). 
DISCUSSION 
Sea anemones produce a wide variety of 
toxic compounds that are mainly stored in their 
nematocysts (72). Among them, actinoporins 
constitute a well-studied family of toxic pore-
forming proteins (3,4,70). It has been long time 
known that individual sea anemones species 
produce many different actinoporins isoforms 
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which, indeed, are very differently represented in 
terms of the amount present in their venomous 
secretions. In this regard, actinoporins represent a 
well-established example of a multigenic protein 
family (38,39,43,45,46,51,73). They are not, 
however, the only example of toxic pore-forming 
multigene protein families (74), suggesting that the 
results shown now could be of larger significance 
and not only restricted to the actinoporins family. 
In fact, it has been very recently suggested that the 
pore responsible for damaging michondria during 
apoptosis could be made of hetero-oligomers of 
the Bax and Bak proteins (75). The natural 
biological function of this genetic multiplicity is 
indeed far from being understood. Regarding the 
actinoporins family, it has been proposed that the 
existence of multiple isoforms would broaden the 
range of possible prey for a given species 
(38,39,43,45,46,51,73). In this regard, actinoporins 
might be similar to immunoglobulins, which 
require a plethora of highly diverse genes to 
counteract foreign antigens (45). 
Here, we propose a complementary 
hypothesis to explain the evolutionary advantage 
of multigenic actinoporins: formation of mixed 
functional pores. This mechanism would enable a 
much wider and finely tuned modulation of their 
toxicity and specificity. These results support the 
feasibility of this novel hypothesis. 
StnI and StnII are two of the best well 
studied actinoporins and also constitute an 
optimum example of two almost identical isoforms 
(they share 91.0% of amino acid sequence 
identity) produced by the same sea anemone 
species but showing very different hemolytic 
activities (24,47,50,76). Consequently, they were 
the model proteins chosen to study the possibility 
of molecularly different actinoporins assembling 
into the same functional pore structure. Indeed, the 
employment of independently produced and 
isolated recombinant protein species excludes 
artifacts produced by traces of cross-contamination 
in the experiments shown that were made with 
only one single protein component. 
Actinoporins pore-structure and 
stoichiometry is still highly controversial and far 
from being solved (22,36,66,69,70,77-79). The 
latest actinoporin pore-like oligomeric structure 
published is a crystalline octameric ensemble of 
FraC (66). According to those results, the two 
side-chain residues showing more buried surface 
upon oligomerization would be FraC Val60 and 
Trp149 (66,80). These residues have their 
corresponding counterparts in StnI (Ile 59 and 
Trp149) and StnII (Ile58 and Trp146). Both amino 
acids could nicely perform an identical function in 
the StnI-StnII mixed oligomers. Therefore, from a 
molecular point of view there would not be 
impediment for the formation of StnI-StnII 
heteropores. 
Synergistic activity of StnI and StnII in 
both hemolysis and calcein-release experiments 
suggested that both proteins are in fact able to 
interact within the same pore structure (Figs. 1 to 
3). Cross-linking experiments further support this 
observation since, and only in the presence of lipid 
vesicles, both StnI and StnII could be cross-linked 
with a short cross-linking agent (Figs. 4 and 5). 
Finally, we have also shown that mixtures of StnI 
and StnII show increased affinity for lipid vesicles, 
in agreement with the fact that both isoforms 
interact in the process of membrane binding and 
pore formation (Fig. 7). ITC and hemolytic 
experiments also show that 1.0% of StnII 
dramatically enhances StnI binding to lipid model 
vesicles driving a dramatic improvement of 
hemolytic activity. Taking into account the only 
moderate effects observed in calcein-leakage 
experiments, and the hemolysis results obtained 
with the two different StnII mutants used as 
control (Fig. 2), it can be also suggested that 
synergy between StnI and StnII could be mostly 
due to a better interaction with the membrane 
while the final step of pore formation would not be 
strongly affected. 
As stated above, actinoporins represent 
multigene families. However, only two or three 
different isoforms are usually produced by the 
same sea anemone species in enough amount as to 
be detected and purified. For example, up to 19 
different cDNA sequences have been detected for 
S. helianthus, the sea anemone producing StnI and 
StnII (43). Thus, taking into account this 
discrepancy between the number of actinoporin 
encoding genes found in sea anemones and the 
amount and diversity of isotoxins made, it is 
tempting to speculate that the less represented 
isoforms might play a role in regulating and/or 
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potentiating the activity and specificity of those 
ones produced in larger amount. Maybe this is just 
a strategy to fulfill a much more modulated and 
specific cytotoxic action against potential prey 
and/or predators. 
Conclusions 
Overall, the results presented here show 
that two different actinoporins produced by the 
same sea anemone species act in synergy, most 
probably interacting to form functional pores made 
of distinct protein isoforms. As far as we know, 
this observation has not been reported before. This 
interaction has sound consequences in terms of the 
biological functionality of actinoporins and 
suggests that it could represent a more general 
strategy employed by other pore forming proteins. 
According to the results reported now, it can be 
speculated that one of the reasons for actinoporins 
being multigene families is the possibility of 
interaction among different isotoxins to exert a 
much more modulated and/or potentiated action 
against their prey and/or predators. This possibility 
would translate into more versatile defense and/or 
attack responses in their natural environment.
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Table 1. Binding of StnI, StnII, or different StnI:StnII mixtures to DOPC:SM:Chol (1:1:1) vesicles studied by ITC. Thermodynamic parameters for 
protein mixtures StnI:StnII (95:5), StnI:StnII (90:10), and StnI:StnII (80:20) (Fig. 7) should be considered only as estimations and are shown only 
for trend consistency purposes because binding affinities were so high that keeping the c values within range involved dilutions below the 
recommended detection limits of the instrument. Therefore, the corresponding c values of the three mixtures containing the higher proportion of 
StnII are high above the recommended ones. Results shown are the average of at least three separate experiments. 
a (30). 
b Relative membrane binding [n(StnII) × K(other)]/[n(other) × K(StnII)] as explained in (30). 
 
 StnI:StnII 
(100:0) 
StnI:StnII 
(0:100)a 
StnI:StnII 
(99:1) 
StnI:StnII 
(95:5) 
StnI:StnII 
(90:10) 
StnI:StnII 
(80:20) 
n 49±1 39 ±4 38±1 42±1 38±1 47±9 
Ka (M-1) x 10-8 0.41±0.03 1.70±0.90 2.84±0.91 33.90±41.90 23.20±19.90 237.00±29.30 
ΔG (kcal/mol) -8.21±0.03 -9.10±0.50 -10.90±0.48 -10.89±0.48 -10.73±0.37 -11.54±1.29 
ΔH (kcal/mol) -20.9±2.1 -44.0±3.0 -9.1±0.1 -11.1±0.1 -14.0±0.1 -27.3±3.2 
ΔS (cal/mol·K) -42.84±6.78 -115±9.00 -1.2±0.73 -0.8±2.0 -14.0±1.7 -52.9±6.4 
[Protein] 10.0 µM 1.5 µM 1.5 µM 1.5 µM 1.5 µM 1.0 µM 
c=Ka x [Protein] 410 255 426 5090 3480 23700 
RBMb 0.19 1.00 1.71 5.50 4.20 115.7 
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The abbreviations used are: 6HStnII, sticholysin II tagged wit six histidine residues at the amino-
terminus; CD, circular dichroism; DMSO, dimethyl sulfoxide; DOPC, 1,2-dioleoyl-sn-glycero-3-
phosphocholine; DSS, disuccinimidyl suberate; EqtII, equinatoxin II; ITC, isothermal titration 
calorimetry; LUV, large unilamellar vesicle; PFT, pore forming toxin; POC, phosphocholine; RMB, 
relative membrane binding; SD, standard deviation; SM, sphingomyelin; Stn, sticholysin. 
FIGURE LEGENDS 
FIGURE 1. (Left panel) Maximum hemolytic rate values (expressed as percentage of hemolysis per 
second) are represented versus the logarithm of total protein concentration: StnI (white dots), StnII 
(black dots), and the StnI:StnII (80:20) mixture (black squares). The white squares line was 
obtained as the arithmetical addition of the rates obtained with the individual proteins for the real 
concentration of each one in the different mixtures employed. Results shown are the average of four 
independently performed experiments. Each of these experiments was made by duplicate. Error bars 
represent ±SD. (Right panel) As a representative example, the hemolytic activity curves of StnI 
(white dots), StnII (black dots), or a StnI:StnII (80:20) mixture (black squares), at a total protein 
concentration of 2 nM, are also shown. 
FIGURE 2. Maximum hemolytic rate values (expressed as percentage of hemolysis per second) are 
represented versus the logarithm of total protein concentration of individual and two different 
actinoporin mixtures: Wild-type StnI and A10PS28P (A) or Y111N (B) StnII mutants. In both 
panels it is shown the behavior of StnI (white dots), the StnII mutant (black dots), and the StnI:StnII 
mutant (80:20) mixture (black squares). The white squares line was obtained as the arithmetical 
addition of the rates obtained with the individual proteins for the real concentration of each one in 
the different mixtures employed. Results shown are the average of four independently performed 
experiments. Each of these experiments was made by duplicate. Error bars represent ±SD. 
FIGURE 3. (Left panel) Calcein release maximal rates (expressed as normalized fluorescence 
intensity increment per second) are represented versus the total protein concentration: StnI (white 
dots), StnII (black dots), and the StnI:StnII (80:20) mixture (black squares). The white squares line 
was obtained as the arithmetical addition of the rates obtained with the individual proteins taking 
into account the real concentration of each one of them in the different mixtures employed. Results 
shown are the average of three independently performed experiments. Each of these experiments 
was made by duplicate. Error bars represent ±SD. (Right panel) As a representative example, the 
calcein leakage traces of StnI (white dots), StnII (black dots), or a StnI:StnII (80:20) mixture (black 
squares), at a total protein concentration of 5 nM, are also shown. 
FIGURE 4. Immunoblotting detection of 6HStnII previously incubated in the presence, or not, of 
wild-type StnI, DOPC:SM:Chol (1:1:1) phospholipid vesicles, and/or DSS, as indicated. Proteins 
were detected using a mouse monoclonal anti-poly-Histidine-peroxidase antibody. The amount of 
6HStnII loaded was 2.5 pmol. The StnI:6HStnII molar ratio employed was 80:20 in all instances 
shown. Molecular weight standards (EZ-RUNTM pre-stained Rec Protein Ladder) were also loaded 
and the corresponding molecular masses are indicated in KDa at the left side margin of the figure. 
FIGURE 5. Coomassie Blue stained gel (upper panel) and the corresponding immunoblotting 
detection (lower panel) of 6HStnII titrated with increasing amount of StnI are shown. The proteins, 
and also the mixtures assayed, were incubated in the presence, or not, of wild-type StnI, 
DOPC:SM:Chol (1:1:1) phospholipid vesicles, and/or DSS, as indicated. Proteins were detected 
using a mouse monoclonal anti-poly-Histidine-peroxidase antibody. The amount of 6HStnII loaded 
was 2.5 pmol in all instances shown. The StnI:6HStnII molar ratio employed is also indicated. 
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Molecular weight standards (EZ-RUNTM pre-stained Rec Protein Ladder) were also loaded and the 
corresponding molecular masses are indicated in KDa at the left side margin of the figure. 
FIGURE 6. Binding of StnI and StnII to DOPC:SM:Chol (1:1:1) vesicles studied by ITC. Reactant 
concentrations were those ones shown in Table 1. Binding isotherms were adjusted to a model in 
which protein membrane binding involves the participation of “n” lipid molecules (30). The c 
values (c = Ka × P0) for the graphs shown were within the range 1–1000. 
FIGURE 7. Binding of StnI, StnII, and different StnI:StnII mixture (molar ratios as indicated) to 
DOPC:SM:Chol (1:1:1) vesicles studied by ITC. Reactant concentrations for the examples shown 
were P0 = 1.5 μM and L0 = 0.85 mM for all experiments shown, where P0 refers to the initial total 
protein concentration within the calorimeter cell and L0 is the lipid concentration within the 
dispensing auto-pipette. Binding isotherms were adjusted to a model in which protein membrane 
binding involves the participation of “n” lipid molecules (30). The c values (c = Ka × P0) for the 
graphs shown were in the 1–1000 range only for the StnI:StnII (0:100), StnI:StnII (99:1), and 
StnI:StnII (100:0). In the other three thermograms shown binding affinities were so high that 
keeping the c values within range involved dilutions below the recommended detection limits of the 
instrument. 
FIGURE 8. (Left panel) Maximum hemolytic rate values (expressed as percentage of hemolysis per 
second) are represented versus the logarithm of total protein concentration of StnI (white dots) and 
an StnI:StnII (99:1) mixture (black squares). In these experiments the amount of StnII present in all 
the mixtures was so low that, when assayed in the absence of StnI, its hemolytic activity was 
undetectable in the time range measured. Results shown are the average of four independently 
performed experiments. Each of these experiments was made by duplicate. Error bars represent 
±SD. (Right panel) As a representative example, the hemolytic activity curves of StnI at 3.96 nM 
(white dots), StnII at 0.04 nM (black dots) and the corresponding StnI:StnII (99:1) 4 nM mixture 
(black squares) are also shown. 
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